Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

Results 1-10 of 59 (Search time: 0.006 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic reviewBain, E.; Middleton, P.; Crowther, C.
2013Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA) -study protocolCrowther, C.; Middleton, P.; Wilkinson, D.; Ashwood, P.; Haslam, R.
2012Antenatal corticosteroids: too much of anything is bad? ReplyMcKinlay, C.; Harding, J.; Crowther, C.; Middleton, P.
2008Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcomeBuchanan, S.; Crowther, C.; Levett, K.; Middleton, P.; Morris, J.
2007Antenatal magnesium sulphate neuroprotection in the preterm infantMarret, S.; Doyle, L.; Crowther, C.; Middleton, P.
2011Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomesCrowther, C.; McKinlay, C.; Middleton, P.; Harding, J.
2009Interventions for clinical and subclinical hypothyroidism in pregnancyReid, S.; Middleton, P.; Crowther, C.; Cossich, M.
2013Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New ZealandBain, E.; Bubner, T.; Ashwood, P.; Crowther, C.; Middleton, P.
2013The DIAMIND study: postpartum SMS reminders to women who have had gestational diabetes mellitus to test for type 2 diabetes: a randomised controlled trial - study protocolHeatley, E.; Middleton, P.; Hague, W.; Crowther, C.
2000Anti-D administration after childbirth for preventing Rhesus alloimmunisationCrowther, C.; Middleton, P.